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The Critical Care Canada Forum was held in Toronto,
Canada from 11 to 13 November 2008. This internationally
recognized conference focuses on topics relevant to the care
of critically ill patients, wherever these patients are located.
The conference was attended by 1,146 healthcare profes-
sionals and featured 191 presentations covering many
diverse topics; the results of several clinical trials were
presented for the first time and ahead of print. In the present
article we summarize some of the highlights of this meeting.
Mechanical ventilation
Dr Daniel Talmor (Boston, MA, USA) presented, for the first
time, the results of a trial of positive end-expiratory pressure
titration using esophageal pressure measurements (to esti-
mate transpulmonary pressure) versus positive end-expiratory
pressure titration according to the Acute Respiratory Distress
Syndrome Network standard-of-care recommendations in
patients with acute lung injury or acute respiratory distress
syndrome [1]. The study reached its early stopping criterion
and was terminated after enrolling only 61 patients; the ratio
of the partial pressure of oxygen to the fraction of inspired
oxygen at 72 hours was 88 mmHg higher in the esophageal-
pressure-guided group (95% confidence interval, 78.1 to
98.3). A dynamic discussion subsequently ensued, during
which several audience members applauded the use of
physiology-guided mechanical ventilation, while others
argued that a multicenter trial studying clinical endpoints
meaningful to patients and clinicians should be conducted to
confirm the anticipated benefits of positive end-expiratory
pressure titration using esophageal probes.
Later in the conference, Dr Luciano Gattinoni (Milano, Italy)
eloquently described how secondary lung injury from
barotrauma and volutrauma might be reduced by mechanical
ventilation in the prone position [2,3]. Published trials,
however, have not yet established an overall survival benefit
[4-6], and two recent meta-analyses [7,8] did not support
prone positioning in the routine management of acute lung
injury and acute respiratory distress syndrome. Dr Gattinoni
showed that if the results of all trials are pooled [4-6] there is
a trend towards improved survival when the analyses are
restricted to the most severe cases of acute respiratory
distress syndrome (n = 150; prone 6-month mortality 45.3%
versus supine 6-month mortality 58.1%, P = 0.057). Dr
Gattinoni then presented unpublished results from his new
clinical trial of prone positioning versus conventional (supine)
mechanical ventilation, which showed no difference overall
but a trend towards improved survival with prone positioning
in patients having the lowest ratios of the partial pressure of
oxygen to the fraction of inspired oxygen [9]. He stressed
that prone positioning relieves severe hypoxemia, and
suggested that overly inclusive patient selection might have
precluded previous clinical trials from demonstrating a
survival benefit.
In a final plenary session, Dr Marco Ranieri (Turin, Italy) pre-
sented late-breaking results from a trial of early (days 3 to 5)
versus late (days 10 to 12) tracheostomy on the incidence of
ventilator-acquired pneumonia. Patients in the early tracheo-
stomy group had shorter total duration of mechanical ventila-
tion and intensive care unit (ICU) stay, and there were non-
significant trends towards reduced ventilator-acquired pneu-
monia and ICU mortality [10]. Editorial comments provided by
Dr Niall Ferguson (Toronto, ON, Canada) agreed that Dr
Ranieri’s results were indeed exciting, but cautioned that the
trial was underpowered to conclude that the observed
mortality difference was not simply due to chance or an
imbalance in important patient and clinical characteristics.
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Sedation and analgesia
Two trials comparing ICU sedation with dexmedetomidine
versus benzodiazepines were presented in an exciting
session on sedation and analgesia. First, Dr Pratik Pandhari-
pande (Memphis, TN, USA) presented results from the recent
Maximizing Efficacy of Targeted Sedation and Reducing
Neurological Dysfunction (MENDS) trial [11], in which 106
mechanically ventilated patients from two centers were
randomly assigned to receive sedation with lorazepam versus
dexmedetomidine infusions for up to 120 hours. Patients in
the dexmedetomidine group had more days alive without
delirium or coma (median days 7.0 versus 3.0, P = 0.01), but
there were no significant differences for 28-day mortality or
cost of care. Results from the unpublished multinational
Safety and Efficacy of Dexmedetomidine Compared to
Midazolam (SEDCOM) trial were then presented by Dr Yahya
Shehabi (Sydney, Australia). In this trial, 366 patients were
randomly assigned to receive either continuous infusion of
dexmedetomidine or midazolam (until extubation or 30 days).
Patients in the dexmedetomidine group developed less
delirium (22.6% lower incidence, P <0.001) and had shorter
time to extubation (3.7 days versus 5.6 days, P = 0.005).
Both authors concluded that these two studies should help
reassure clinicians about dexmedetomidine’s safety and its
potential ability to reduce delirium in the ICU.
The results of the Awakening and Breathing Controlled Trial
[12] were also presented at the conference, by Dr Timothy
Girard (Nashville, TN, USA). This trial randomly assigned
patients from four centers to management using a protocol
incorporating both daily interruption of sedation and a
spontaneous breathing trial versus a protocol for daily
spontaneous breathing trials only. Patients in the interruption
of sedation and spontaneous breathing trial group spent
more days breathing without assistance during the 28-day
study period than did those in the spontaneous breathing
trial-only group (14.7 days versus 11.6 days, P = 0.02), and
were discharged from the ICU earlier (mean time in ICU, 9.1
days versus 12.9 days, P = 0.01). While some audience
members expressed concerns that patients in the control
group may have received spontaneous breathing trials while
still being sedated, Dr Girard maintained that pairing of daily
spontaneous awakening trials with daily spontaneous
breathing trials resulted in better outcomes in his trial and
should therefore become routine practice.
Glycemic control
This year’s Critical Care Canada Forum featured many
sessions discussing the optimal control of hyperglycemia in
the ICU. A highlight of this track was the first-ever presen-
tation of the results of a randomized controlled trial of
intensive insulin therapy in critically ill patients by Dr Yaseen
Arabi (Riyadh, Saudi Arabia). In this trial, 523 medical
surgical ICU patients were randomly assigned to receive
intensive insulin therapy (target glucose 4.4 to 6.1 mmol/l) or
conventional insulin therapy (target glucose 10.0 to
11.1 mmol/l). No significant differences were observed
between the two groups comparing hospital mortality, ICU or
hospital length of stay, mechanical ventilation duration, need
for dialysis, or rate of acquired infections. Hypoglycemia
occurred more frequently, however, with intensive insulin
therapy (28.6% versus 3.1% of patients, P < 0.0001) [13]. At
the conclusion of the exciting presentation, the audience was
left anticipating the results of the recently completed
international, multicentered Normoglycemia in Intensive Care
Evaluation Using Glucose Algorithm Regulation trial that will
address a similar study question in 6,100 patients [14].
Critical care on the global stage
A new track at Critical Care Canada Forum 2008 focused on
the delivery of critical care on the global stage. In a series of
talks by Dr Robert Fowler (Toronto, ON, Canada), Dr Jean-
Louis Vincent (Brussels, Belgium), Dr Fabrice Brunet
(Toronto, ON, Canada) and Dr Tex Kissoon (Vancouver, BC,
Canada), the audience was persuaded that regional and
national critical care challenges are also pertinent to ICU
practice worldwide. Regional problems, however, often
become exaggerated on the global scale; for example,
increased burden of illnesses, deficits in educational and
research infrastructure, and poor access to medical supplies,
and diagnostic and therapeutic equipment [15]. The
presenters stressed that while we are trying to solve pressing
issues here at home, we must also be concerned with the
needs of developing countries.
Conclusions
This brief synopsis covers only a small sample of the content
from the 2008 Toronto Critical Care Canada Forum. Many
presentations also covered a diverse range of topics
including ICU infections, glycemic control, cardiovascular
disease, outreach and critical care response teams,
neuroprotection and neuromonitoring, pandemic planning
and pediatric critical care issues.
The 3-day conference was an enormous success, and
planning is already underway for next year’s event
(www.criticalcarecanada.com). Save the date: 25–28
October 2009!
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